Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis.
<h4>Background</h4>We aimed to investigate the association of serum pentadecanoic acid (15:0), a biomarker of dairy fat intake, with incident cardiovascular disease (CVD) and all-cause mortality in a Swedish cohort study. We also systematically reviewed studies of the association of dair...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1e99cb1dce64198bcdfd4b8e64ea849 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a1e99cb1dce64198bcdfd4b8e64ea849 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a1e99cb1dce64198bcdfd4b8e64ea8492021-12-02T19:56:03ZBiomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis.1549-12771549-167610.1371/journal.pmed.1003763https://doaj.org/article/a1e99cb1dce64198bcdfd4b8e64ea8492021-09-01T00:00:00Zhttps://doi.org/10.1371/journal.pmed.1003763https://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>We aimed to investigate the association of serum pentadecanoic acid (15:0), a biomarker of dairy fat intake, with incident cardiovascular disease (CVD) and all-cause mortality in a Swedish cohort study. We also systematically reviewed studies of the association of dairy fat biomarkers (circulating or adipose tissue levels of 15:0, heptadecanoic acid [17:0], and trans-palmitoleic acid [t16:1n-7]) with CVD outcomes or all-cause mortality.<h4>Methods and findings</h4>We measured 15:0 in serum cholesterol esters at baseline in 4,150 Swedish adults (51% female, median age 60.5 years). During a median follow-up of 16.6 years, 578 incident CVD events and 676 deaths were identified using Swedish registers. In multivariable-adjusted models, higher 15:0 was associated with lower incident CVD risk in a linear dose-response manner (hazard ratio 0.75 per interquintile range; 95% confidence interval 0.61, 0.93, P = 0.009) and nonlinearly with all-cause mortality (P for nonlinearity = 0.03), with a nadir of mortality risk around median 15:0. In meta-analyses including our Swedish cohort and 17 cohort, case-cohort, or nested case-control studies, higher 15:0 and 17:0 but not t16:1n-7 were inversely associated with total CVD, with the relative risk of highest versus lowest tertile being 0.88 (0.78, 0.99), 0.86 (0.79, 0.93), and 1.01 (0.91, 1.12), respectively. Dairy fat biomarkers were not associated with all-cause mortality in meta-analyses, although there were ≤3 studies for each biomarker. Study limitations include the inability of the biomarkers to distinguish different types of dairy foods and that most studies in the meta-analyses (including our novel cohort study) only assessed biomarkers at baseline, which may increase the risk of misclassification of exposure levels.<h4>Conclusions</h4>In a meta-analysis of 18 observational studies including our new cohort study, higher levels of 15:0 and 17:0 were associated with lower CVD risk. Our findings support the need for clinical and experimental studies to elucidate the causality of these relationships and relevant biological mechanisms.Kathy TrieuSaiuj BhatZhaoli DaiKarin LeanderBruna GiganteFrank QianAndres V Ardisson KoratQi SunXiong-Fei PanFederica LaguzziTommy CederholmUlf de FaireMai-Lis HelléniusJason H Y WuUlf RisérusMatti MarklundPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 18, Iss 9, p e1003763 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R |
spellingShingle |
Medicine R Kathy Trieu Saiuj Bhat Zhaoli Dai Karin Leander Bruna Gigante Frank Qian Andres V Ardisson Korat Qi Sun Xiong-Fei Pan Federica Laguzzi Tommy Cederholm Ulf de Faire Mai-Lis Hellénius Jason H Y Wu Ulf Risérus Matti Marklund Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis. |
description |
<h4>Background</h4>We aimed to investigate the association of serum pentadecanoic acid (15:0), a biomarker of dairy fat intake, with incident cardiovascular disease (CVD) and all-cause mortality in a Swedish cohort study. We also systematically reviewed studies of the association of dairy fat biomarkers (circulating or adipose tissue levels of 15:0, heptadecanoic acid [17:0], and trans-palmitoleic acid [t16:1n-7]) with CVD outcomes or all-cause mortality.<h4>Methods and findings</h4>We measured 15:0 in serum cholesterol esters at baseline in 4,150 Swedish adults (51% female, median age 60.5 years). During a median follow-up of 16.6 years, 578 incident CVD events and 676 deaths were identified using Swedish registers. In multivariable-adjusted models, higher 15:0 was associated with lower incident CVD risk in a linear dose-response manner (hazard ratio 0.75 per interquintile range; 95% confidence interval 0.61, 0.93, P = 0.009) and nonlinearly with all-cause mortality (P for nonlinearity = 0.03), with a nadir of mortality risk around median 15:0. In meta-analyses including our Swedish cohort and 17 cohort, case-cohort, or nested case-control studies, higher 15:0 and 17:0 but not t16:1n-7 were inversely associated with total CVD, with the relative risk of highest versus lowest tertile being 0.88 (0.78, 0.99), 0.86 (0.79, 0.93), and 1.01 (0.91, 1.12), respectively. Dairy fat biomarkers were not associated with all-cause mortality in meta-analyses, although there were ≤3 studies for each biomarker. Study limitations include the inability of the biomarkers to distinguish different types of dairy foods and that most studies in the meta-analyses (including our novel cohort study) only assessed biomarkers at baseline, which may increase the risk of misclassification of exposure levels.<h4>Conclusions</h4>In a meta-analysis of 18 observational studies including our new cohort study, higher levels of 15:0 and 17:0 were associated with lower CVD risk. Our findings support the need for clinical and experimental studies to elucidate the causality of these relationships and relevant biological mechanisms. |
format |
article |
author |
Kathy Trieu Saiuj Bhat Zhaoli Dai Karin Leander Bruna Gigante Frank Qian Andres V Ardisson Korat Qi Sun Xiong-Fei Pan Federica Laguzzi Tommy Cederholm Ulf de Faire Mai-Lis Hellénius Jason H Y Wu Ulf Risérus Matti Marklund |
author_facet |
Kathy Trieu Saiuj Bhat Zhaoli Dai Karin Leander Bruna Gigante Frank Qian Andres V Ardisson Korat Qi Sun Xiong-Fei Pan Federica Laguzzi Tommy Cederholm Ulf de Faire Mai-Lis Hellénius Jason H Y Wu Ulf Risérus Matti Marklund |
author_sort |
Kathy Trieu |
title |
Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis. |
title_short |
Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis. |
title_full |
Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis. |
title_fullStr |
Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis. |
title_full_unstemmed |
Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis. |
title_sort |
biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: a cohort study, systematic review, and meta-analysis. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/a1e99cb1dce64198bcdfd4b8e64ea849 |
work_keys_str_mv |
AT kathytrieu biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT saiujbhat biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT zhaolidai biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT karinleander biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT brunagigante biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT frankqian biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT andresvardissonkorat biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT qisun biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT xiongfeipan biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT federicalaguzzi biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT tommycederholm biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT ulfdefaire biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT mailishellenius biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT jasonhywu biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT ulfriserus biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis AT mattimarklund biomarkersofdairyfatintakeincidentcardiovasculardiseaseandallcausemortalityacohortstudysystematicreviewandmetaanalysis |
_version_ |
1718375857052975104 |